Screening for MASLD by at 29th Annual Virginia Liver Symposium by @juanpabloarab.bsky.social @vculiver.bsky.social 🌎 prevalence of MASLD 30% ⬆️ risk progression with DM, HTN, obesity, menopause Screen for 🍷 ♻️ Putative connection between MASLD, CVD, CKD

Team VCU at AASLD MASLD/MetALD/ALD Emerging Topic Conference 2025, Las Vegas @juanpabloarab.bsky.social @saulkarpen.bsky.social @vculiver.bsky.social

Thank you @aasldnews.bsky.social for the travel grant to present at #AASLDETC in ☀️ Las Vegas Kudos to the organisers @juanpabloarab.bsky.social, Dr Noureddin and team! #HepatologySky

Check out our recently published case report of ICI + CMV colitis, published in @amcollegegastro.bsky.social Case Reports Journal pubmed.ncbi.nlm.nih.gov/39734389/ High-yield flowchart for management of ICIC included! #GISky

A sweet start to 2025! Happy new year to the #LiverSky and #GISky squad 🥳 @amcollegegastro.bsky.social #VCUHealth

Congrats to inspiring investigators @anandvkulkarni.bsky.social @juanpabloarab.bsky.social and team, for late breaking abstract about rapid taper of steroids in AAH at #TLM24 ⤵️ infections, hospitalizations with rapid taper 💫 changing practice in management of AAH #LiverSky #AASLD

Happy to share our findings about naltrexone in decompensated cirrhosis, at #TLM2024. Grateful for the support of my mentors Dr Devuni, @juanpabloarab.bsky.social, and my excellent co-author Dr Cooper! #LiverSky